Drawing for GENIO

USPTO serial 79294758

GENIO

Reviewed by CopyMark Law Group

Reg. 6422421Status 700Renewal
Filing date
Status date
Registration date
Jul 20, 2021
Examiner
RIEPEL, CHRISTINA MAXINE
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with GENIO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,446*

Plus Government fees of $1,300

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

James. L. Bikoff

James. L. Bikoff Smith, Gambrell & Russell LLP1055 Thomas Jefferson Street, NWSuite 400Washington, DC 20007

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for skin care; sanitary preparations for medical purposes; transdermal patches for medical purposes, namely, for use in the treatment of sleep apnea and related sleep disorders; adhesive medical patch containing pharmaceutical preparations primarily for use in the treatment of sleep apnea and related sleep disorders; transdermal patch for medical purposes, namely, for use in the treatment of sleep apnea and related sleep disorders; none of the aforementioned goods for use in the field of dialysis therapy or blood purificationACTIVE—
009Downloadable data management software for use with medical devices for the diagnosis and treatment of sleep apnea and related sleep disorders; downloadable computer software for use with medical equipment for receiving, analyzing, processing, transmitting, and displaying medical data in the field of sleep disorders; connection cables and cable connectors for the aforesaid goods, namely, medical devices for the diagnosis and treatment of sleep apnea and related sleep disorders; rechargeable batteries for medical devices; charging appliances for rechargeable equipment, namely, a charging unit for charging an activation device for activating an implantable stimulator; downloadable instruction manuals for medical devices used for the diagnosis and treatment of sleep apnea and related sleep disorders, and electronic publications in the nature of instruction manuals for medical devices used for the diagnoses and treatment of sleep apnea and related sleep disorders recorded on computer media related theretoACTIVE—
010Medical devices for the diagnosis and treatment of obstructive sleep apnea and related sleep disorders and structural parts and fittings therefor; electrical stimulation apparatus for the treatment of obstructive sleep apnea, namely, an implantable nerve or muscle stimulator made of artificial materials, disposable patch, and a device for implanting the stimulator; an activation device specially adapted for activating an implantable nerve or muscle stimulator, an activation device specially adapted for wirelessly activating an implantable nerve or muscle stimulator; an activation device with rechargeable battery specially adapted for activating an implantable nerve or muscle stimulator; sterile external nerve or muscle stimulator for activating the implantable nerve or muscle stimulator; patient screening kits for the diagnosis of sleep apnea and related sleep disorders consisting of a medical device for the diagnosis of obstructive sleep apnea and related sleep disorders, an electronic data recorder for the recording of information collected in the diagnosis of obstructive sleep apnea and related sleep disorders, data management computer software for use with medical devices for the diagnosis of sleep apnea and related sleep disorders, and connection cables, all sold as a unit; electrical stimulation system for health and medical purposes comprised of electronic nerve and muscle stimulators for upper airway stimulationACTIVE—
044Medical services, namely, diagnosis and treatment of obstructive sleep apnea and related sleep disorders; medical consultation services in the field of obstructive sleep apnea and related disorders provided to patients and doctors; providing medical information in the field of sleep apnea and related sleep disorders via a websiteACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 20, 2026REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Nov 21, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Mar 13, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Dec 13, 2021FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Nov 22, 2021FICSFINAL DISPOSITION NOTICE SENT TO IB—
Nov 22, 2021FIMPFINAL DISPOSITION PROCESSED—
Oct 20, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 20, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 4, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 4, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 2, 2021GPNXNOTIFICATION PROCESSED BY IB—
Apr 14, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 14, 2021OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Apr 14, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 1, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 25, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 25, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 25, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 25, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 25, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 25, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 25, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Mar 25, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 22, 2020RFNTREFUSAL PROCESSED BY IB—
Nov 13, 2020NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 3, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Nov 3, 2020RFRRREFUSAL PROCESSED BY MPU—
Oct 10, 2020MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 9, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Oct 8, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 6, 2020DOCKASSIGNED TO EXAMINER—
Oct 6, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 1, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance